Initial intensive combined chemotherapy, with late re-operation when indicated, appears to give better results than immediate excision of the infected valve.
Introduction
Cardiac valve replacement is associated with a higher susceptibility to infective endocarditis (Wilson, 1977) and fungal endocarditis is particularly dangerous because of the problem of antifungal chemotherapy (McLeod and Remington, 1977) . Antibiotic sterilized homograft valves have been used since 1968 (Stinson et al., 1968; Barratt-Boyes and Roche, 1969; Yacoub and Kittle, 1970; Lockey et al., 1972) and are considered by the authors to be one of the best available valve substitutes. cumbed to a recurrence of the infection more than 3 months after the immediate re-operation. Only one patient survived for more than 4 months and in that case there was a recurrence of the infection and re-operation was followed by an overwhelming infection which did not respond to chemotherapy.
Intensive initial chemotherapy
Sixteen patients were treated with intensive initial chemotherapy and 9 of these did not undergo subsequent re-operation. Three of these died within 2 weeks of diagnosis, owing to uncontrolled infection. Two more died within 6 weeks with some indication of drug toxicity and fungal toxaemia. One patient refused re-operation and died after 11 months and 3 patients are alive, 15 to 27 months after the start of chemotherapy. It is anticipated that these 3 patients will eventually require a re-operation to replace the damaged valve Seven of the 16 patients who received intensive initial chemotherapy have had a re-operation to replace the valve. The operation was necessary because of the patient's cardiac status and was performed 2 weeks after initiation of chemotherapy in one case and after 40 months in another. One of these patients died, with a low cardiac output, within 5 days of the re-operation at 10 months and the remaining 6 are alive 33 to 87 months after endocarditis, an average survival of 50 months. Nine of these 16 patients, treated with intensive initial chemotherapy are alive 15 to 87 months after the onset of the infection, an average survival of 40 months without evidence of recurrence.
Complications of chemotherapy
All 18 patients treated with chemotherapy for more than 2 weeks, including 3 patients who underwent re-operation, experienced some temporary renal disturbance. Sometimes this was sufficiently severe to modify the dose of amphotericin B therapy. Seven of these 18 patients experienced some gastrointestinal disturbance and 4 succumbed to a recurrence of their uncontrolled infection. One patient developed agranulocytosis whilst on flucytosine, but this was thought to be secondary to acute streptococcal septicaemia (superinfection) and was successfully treated with antibiotics and blood transfusion. This patient was then treated with flucytosine for a further 5 months with a maintaining leucocyte count in excess of 5000/mm3. There was one patient who developed jaundice with temporary hepatic disturbance and one patient who attempted suicide.
Complications of infection
Other complications associated with the endocarditis included 12 emboli, 8 of which were removed and 3 mycotic aneurysms, 2 of which were excised and a section of the affected artery replaced with autogenous saphenous vein. Seven of the 8 patients who underwent embolectomy have survived for 17 to 87 months as have the 2 patients from whom the aneurysms were excised. Two other patients developed terminal gangrene with multiple peripheral emboli.
Serology
Initial agglutination titres to C. albicans varied from 1/21 to 1/512 and generally fell to 1/20 to 1/64 by 4 months. Two of the patients who died during chemotherapy showed a rise in titre (1/160 to 1/320; 1/64 to 1/128) but generally a sustained fall in the agglutination titre was used to support the decision to stop amphotericin B therapy at 6 weeks.
Discussion
Nine (33%°) patients who have not shown any sign of recurrence between 17 and 87 months after treatment of fungal endocarditis were considered as examples of successful chemotherapy. The deaths of 11 (41 %) of the patients within 2 weeks of the diagnosis of fungal endocarditis probably represents uncontrolled fulminating infection. The inability to control the infection over several months in a further 3 patients who had required an immediate reoperation for severe haemodynamic reasons is seen as support for the policy of intensive initial chemotherapy. This policy is based on the belief that the trauma of cardiopulmonary bypass surgery imposes an unacceptable strain on such acutely ill patients. It is believed that an immediate re-operation affects the patient's defence system and permits a subsequent flare-up of the systemic infection which cannot adequately be controlled by chemotherapy. In contrast, intensive initial chemotherapy, to control the infection, can permit the patient to recover from the acute symptoms of endocarditis. The cardiac status of the patient may then be assessed and a decision made about the eventual replacement of the affected valve. The effectiveness of this policy is supported by the fact that 9 (69%) of the 16 patients who received intensive initial chemotherapy for more than 2 weeks have a long-term survival of 17-87 months. 
